banner
dufourjf.bsky.social
@dufourjf.bsky.social
Reduction of HCC risk with GLP-1RA in diabetics? Comparisons between the GLP-1RA use group (n = 215,970) and the usual care group who continued use of non-GLP-1RA antihyperglycemics (n = 1,203,097), from the VA database. Risk reduction 18%.
shorturl.at/cl2Nc
March 13, 2025 at 3:57 PM
In compensated MASLD-cirrhosis metabolic surgery reduces the 15 year cumulative incidence of major adverse liver outcomes (MALO) (21% vs 46% without surgery) !⚠️observational study.
shorturl.at/LKnMa
March 12, 2025 at 4:35 PM
Autologous macrophage therapy for cirrhosis: phase 2 open-label randomized controlled trial: During 360-d follow-up, control group developed 4 liver related events, and 3 deaths (2 liver related), whereas no liver-related severe adverse events or deaths occurred in the treatment group.
January 11, 2025 at 9:45 AM
More on coffee benefits. Timing. Beginning your day with a coffee rather than finishing your day with a coffee is associated with a reduced mortality risk. shorturl.at/WGErS
January 9, 2025 at 6:31 AM
In contrast to liver-specific MASLD (blue), cardiometabolic MASLD (red, characterized by dyslipidemia, hypertension, dysglycemia) results in a high risk of incident cardiovascular disease. shorturl.at/ZhFRC
January 6, 2025 at 7:23 AM
Hepatic TM6SF2 activates antitumour immunity to
suppress MASLD-related HCC shorturl.at/M33WJ
January 1, 2025 at 6:32 AM
Generally, women live longer than men, but not after the diagnosis of HCC. See doi: 10.3390/cancers16234023.
December 23, 2024 at 6:46 AM